Secretory carcinoma presenting as a nodular mass in the buccal tissues

[1]  T. Ogawa,et al.  Parotid secretory carcinoma with high-grade transformation. , 2020, Auris, nasus, larynx.

[2]  T. Yoon,et al.  Outcomes of treatment of mammary analogue secretory carcinoma of the parotid gland. , 2019, The British journal of oral & maxillofacial surgery.

[3]  E. Omoscharka,et al.  Mammary analogue secretory carcinoma of salivary gland diagnosed on submandibular gland cytology: A case report and review of the literature , 2019, Cytopathology : official journal of the British Society for Clinical Cytology.

[4]  R. Seethala,et al.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland , 2017, Head and Neck Pathology.

[5]  M. Ladanyi,et al.  What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  T. Vaněček,et al.  Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation: Report of 3 Cases With the ETV6-NTRK3 Gene Fusion and Analysis of TP53, &bgr;-Catenin, EGFR, and CCND1 Genes , 2014, The American journal of surgical pathology.

[7]  Simion I. Chiosea,et al.  Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands , 2012, Histopathology.

[8]  B. Perez-Ordonez,et al.  Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity , 2010, The American journal of surgical pathology.

[9]  L. Thuler,et al.  SECRETORY CARCINOMA OF SALIVARY GLANDS: WHERE ARE WE? , 2020 .